The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention

Topcu, Selim; Karal, Huseyin; Kaya, Ahmet; Bakirci, Eftal; Tanboga, İbrahim; Kurt, Mustafa; Aksakal, Enbiya; Acikel, Mahmut; SEVİMLİ, Serdar

doi:10.1177/1076029614529841

The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention

Topcu S., Karal H., Kaya A., Bakirci E. M., Tanboga I. H., Kurt M., ...Daha Fazla

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, cilt.21, sa.8, ss.783-789, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 8
Basım Tarihi: 2015
Doi Numarası: 10.1177/1076029614529841
Dergi Adı: CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.783-789
Anahtar Kelimeler: tirofiban infusion, ST-segment elevation myocardial infarction, primary percutaneous, coronary intervention, IIB/IIIA RECEPTOR ANTAGONISTS, GLYCOPROTEIN IIB/IIIA, MYOCARDIAL-INFARCTION, DOUBLE-BLIND, METAANALYSIS, IMPLANTATION, EPTIFIBATIDE, INHIBITORS, ABCIXIMAB, PLACEBO
Atatürk Üniversitesi Adresli: Evet

Özet

Aim: We aimed to investigate the 6-month efficacy and safety of postprocedural 12-hour tirofiban administration versus 24-hour tirofiban administration in patients with ST-segment elevated myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI).